- Home
- ATLX vs IMAB Comparison
ATLX vs IMAB Comparison
Compare ATLX & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- IMAB
- Stock Information
- Founded
- ATLX 2011
- IMAB 2014
- Country
- ATLX Brazil
- IMAB United States
- Employees
- ATLX N/A
- IMAB N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- ATLX Industrials
- IMAB Health Care
- Exchange
- ATLX Nasdaq
- IMAB Nasdaq
- Market Cap
- ATLX 90.1M
- IMAB 73.9M
- IPO Year
- ATLX N/A
- IMAB 2020
- Fundamental
- Price
- ATLX $3.87
- IMAB $0.94
- Analyst Decision
- ATLX Strong Buy
- IMAB Strong Buy
- Analyst Count
- ATLX 2
- IMAB 2
- Target Price
- ATLX $22.25
- IMAB $5.50
- AVG Volume (30 Days)
- ATLX 151.2K
- IMAB 97.4K
- Earning Date
- ATLX 05-09-2025
- IMAB 04-03-2025
- Dividend Yield
- ATLX N/A
- IMAB N/A
- EPS Growth
- ATLX N/A
- IMAB N/A
- EPS
- ATLX N/A
- IMAB N/A
- Revenue
- ATLX $587,122.00
- IMAB N/A
- Revenue This Year
- ATLX $19,668.81
- IMAB N/A
- Revenue Next Year
- ATLX $43.15
- IMAB N/A
- P/E Ratio
- ATLX N/A
- IMAB N/A
- Revenue Growth
- ATLX 214.46
- IMAB N/A
- 52 Week Low
- ATLX $3.54
- IMAB $0.60
- 52 Week High
- ATLX $17.72
- IMAB $2.00
- Technical
- Relative Strength Index (RSI)
- ATLX 42.16
- IMAB 56.62
- Support Level
- ATLX $4.06
- IMAB $0.85
- Resistance Level
- ATLX $4.57
- IMAB $0.93
- Average True Range (ATR)
- ATLX 0.24
- IMAB 0.06
- MACD
- ATLX 0.04
- IMAB 0.00
- Stochastic Oscillator
- ATLX 34.38
- IMAB 72.50
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).